FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Draft Product-specific ANDA Guidances

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances on ANDA bioequivalence study designs.

latest-news-card-1

DTC Research Supports Disclosures on Endpoint Differentiation

New FDA research on direct-to-consumer television ads finds that disclosures could help viewers in differentiating between progression-free survival a...

latest-news-card-1
Medical Devices

Abiomed Recalls Impella 5.5. Blood Pump

Abiomed recalls its Impella 5.5 with SmartAssist catheter, an intravascular micro axial blood pump that supports a patients circulatory system, due to...

latest-news-card-1
Medical Devices

Zoll Settles Case Against China-made ECG Cables

The Justice Department resolves civil claims requiring Zoll Medical to pay $400,000 for selling Chinese-made products to the federal government.

latest-news-card-1
Human Drugs

Genmab BLA OKd for Large B-cell Lymphoma

FDA grants Genmab an accelerated approval for its BLA for Epkinly (epcoritamab-bysp) injection for treating adult patients with relapsed or refractory...

latest-news-card-1
Biologics

Topical Gene Therapy for Wounds Approved

FDA approves a Krystal Biotech BLA for Vyjuvek, a herpes-simplex virus type 1 vector-based gene therapy for treating wounds in patients older than six...

latest-news-card-1
Medical Devices

Bionic Pancreas Cleared by FDA

FDA clears a Beta Bionics 510(k) for its Bionic Pancreas for treating Type 1 diabetes in patients aged six years and older.

latest-news-card-1
Human Drugs

Revoke Approval for MSNs Generic Hetlioz: Vanda

Vanda calls on FDA to revoke its approval of an MSN Pharmaceuticals ANDA for generic Hetlioz because it says the ANDA does not demonstrate bioequivale...

latest-news-card-1
Human Drugs

Nephron Pharmaceuticals Warehouse FDA-483

FDA releases the form FDA-483 issued following an inspection at the Nephron Pharmaceuticals warehouse in Murray, KY.

latest-news-card-1
Human Drugs

AbbVie Gets Rinvoq OK for Crohns

FDA approves AbbVies Rinvoq (upadacitinib) for treating adults with moderately to severely active Crohns disease.